Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2022 Results Presentation
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on March 1, 2023, at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on March 1, 2023, at 4:30 p.m. ET. This event will review the company's business performance for Q4 and the full year ending December 31, 2022. Details regarding the presentation and a link to the webcast will be available on Ginkgo's investor relations website. Investors can submit questions via Twitter or email prior to the event. Ginkgo Bioworks focuses on cell programming and biosecurity solutions across various industries including food, pharmaceuticals, and public health.
Positive
- Scheduled presentation indicates transparency and engagement with investors.
- Focus on diverse markets can lead to growth opportunities.
Negative
- No specific financial metrics or performance indicators were provided.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was +5.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Presentation and Q&A session scheduled for post-market on Wednesday, March 1, 2023
BOSTON, Feb. 22, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2022, on Wednesday, March 1, 2023, beginning at 4:30 p.m. ET.
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com/events, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2022-results-presentation-301752784.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.